IAPO statements at the WHO Executive Board 148th session, January 2021

The 148th session of the World Health Organization’s Executive Board (EB) took place on 18-26 January 2021 in Geneva, Switzerland with a focus on the challenges of COVID-19, the need to strengthen health systems.

The Governing Board Chair, and Governing Board Secretary were able to attend a variety of sessions where they made statemts on behalf of patients. 

 

IAPO interventions

IAPO delivered the following four statements:

IAPO Statement on EB148/5 – Global action on patient safety

IAPO Statement on EB148/6 – Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases

IAPO Statement on EB148/7 – Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices, etc...

IAPO Statement on EB148/9 – Antimicrobial resistance

 

 

All statements presented by Member States and non-state actors as well as the EB agenda and papers are available on the WHO website here.